Documentary Sensation "The Blue Angels" Soars Back Into Select Imax(R) Theatres as a New Version Offered in Breathtaking New Imax 3D Presentations Across the Globe Starting January 17th ...

Approximately two years ago, in early January 2023, I wrote my last article about Ryder System, Inc. (NYSE: R ). For those not familiar with the business, it operates in the fleet management solutions business. It provides full-service leasing andCrude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential.Subscribers get to use a 50+ stock model account, ...

Ryder System (R) is facing significant freight market challenges. Escalating operating expenses are adversely affecting the company’s bottom line, making it an unattractive choice for investors’ portfolios.Let’s delve deeper.Ryder: Key Risks to WatchSouthward Earnings Estimate Revision:The Zacks Consensus Estimate for 2025 earnings has been revised 1.14% downward over the past 60 days. The unfavorable estimate revision indicates brokers’ lack of confidence in the stock.Dim Price Performance: The company’s p ...

Northvale, New Jersey--(Newsfile Corp. - December 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, today announced that the company has launched Elite's generic version of Vyvanse® (Lisdexamfetamine Disylate) with strengths of 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg and 70 mg capsules. The product is indicated for the treatment of attention deficit hyperactivity disorder (ADHD). This product is marketed ...

Edge Total Intelligence Recognized in the 2024 Gartner(R) Market Guide for Digital Twin of an Organization PlatformsDecember 12, 2024 3:01 AM EST | Source: Edge Total Intelligence Inc.Arlington, Virginia--(Newsfile Corp. - December 12, 2024) - Edge Total Intelligence Inc. (TSXV: CTRL) (OTCQB: UNFYF) (FSE: Q5I) ("edgeTI", "Company"), a leading provider of real-time Digital Operations software that create Digital Twins that enable AI and other digital innovations, announced that it was recognize ...

公司业务更新 - 公司提供关于THERMAL-XR®商业化进展的最新信息 THERMAL-XR®是由GMG石墨烯驱动的 THERMAL-XR®涂层系统是一种独特的提高热交换表面热传递的方法 该过程通过利用GMG石墨烯的物理特性来增加热传递率 从而提高效率并可能减少功耗 [1][8][9] 客户参与更新 - 公司在多个行业中与公司进行测试 包括在电子产品中使用THERMAL-XR® ，特别是在电子产品的热沉中 图1展示了一个涂有THERMAL-XR®的铝制热沉 该热沉通常用于从印刷电路板 电气电路和处理硅芯片中去除热量 [2] 热沉小型化 - 第三方验证的建模显示 应用THERMAL-XR®到热沉上可以将其尺寸减少高达39% 同时保持等效的热性能 这提供了重量和材料成本节省的潜力 图2显示 涂有THERMAL-XR®的热沉达到的最高温度为62摄氏度 比未涂THERMAL-XR®的热沉的最高温度80摄氏度低23% 图3显示 涂有THERMAL-XR®的热沉在宽度上缩小39% 但仍能达到与未涂THERMAL-XR®的热沉相同的性能 [3][4][5] 行业前景 - 全球印刷电路板 PCB 生产预计到2030年将达到每年5.3亿平方米 或约5.3万亿个印刷电路板 随着PCB密度的增加 更高的电流负载导致更多的热量 预计有52亿个单位需要热沉进行冷却 THERMAL-XR®涂层在热沉上 增强了热沉的效率 使得热沉更小 并且PCB组件更紧凑 到2030年 用于此应用以提高性能的THERMAL-XR®总量可能达到每年2650万升 假设0.1%将使用该涂层 [6] 管理层评论 - 公司董事总经理兼首席执行官Craig Nicol表示 热沉是现代电子产品的关键组件 但随着设备变得更小 更快 更强大 它们也带来了各种挑战 GMG的THERMAL-XR®在热沉小型化方面提供了一个潜在的解决方案 能够在保持热性能的同时将尺寸减少高达39% 这不仅有可能降低材料成本 还可能为紧凑高效的电子设计解锁新机会 以应对全球印刷电路板市场日益增长的热管理需求 [7] 公司简介 - GMG是一家清洁技术公司 致力于提供由石墨烯驱动的节能和储能解决方案 包括通过内部专有生产工艺制造的石墨烯 GMG开发了一种专有的生产工艺 将天然气 即甲烷 分解为其元素 碳 氢和一些残留的碳氢气体 该工艺生产出高质量 低成本 可扩展 可调节且低/无污染的石墨烯 适用于清洁技术和其他应用 公司的当前重点是降低风险 发展商业规模化能力 并确保市场应用 在节能领域 GMG专注于石墨烯增强的加热 通风和空调 HVAC-R 涂层 润滑剂和流体 在储能领域 GMG与昆士兰大学合作 在澳大利亚政府的财政支持下 推进石墨烯铝离子电池 G+AI电池 的研发和商业化 [10][11][12] 公司业务目标 - 公司的4个关键业务目标是 1 生产石墨烯并改进/扩展电池生产工艺 2 从节能产品中建立收入 3 开发下一代电池 4 发展供应链 合作伙伴和项目执行能力 [13]

Neos S&P 500(R) High Income ETF BATS: SPYI is an interesting play on the S&P 500 benchmarked to the CBOE’s S&P 500 Buy-Write index. The Buy-Write index tracks potential returns from an S&P 500-oriented covered call strategy, which is the SPYI’s primary focus. It is an actively managed fund utilizing proprietary techniques to pinpoint and profit from options activity, including long and short positions. Because the strategy is buy-focused, the fund is also positioned to increase in value in rising markets, a ...

First Patient Treated with Adaptimmune's TECELRA(R) (afamitresgene autoleucel)Dosing marks a milestone for first engineered cell therapy approved in the U.S. for a solid tumor cancer, synovial sarcomaDecember 02, 2024 4:00 PM EST | Source: Adaptimmune Therapeutics PLCPhiladelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - December 2, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company working to redefine the treatment of solid tumor cancers with cell therapy, today ...

Ryder’s (R) top line is bolstered by its recent acquisitions of Cardinal and IFS, boosting the company’s performance. The shareholder-friendly approach is encouraging. However, R is grappling with weak liquidity and escalated operating expenses.Factors Favoring RRyder's long-standing commitment to sustainability through initiatives like fleet upgrades, reducing truck idling, and improving route efficiency is commendable. A SmartWay partner since 2006, Ryder has earned the Excellence Award six times, demonst ...

Delivra Health Brands and its Leading Brands Dream Water (R) and LivRelief(TM) Report Financial Results for First Quarter of Fiscal 2025November 25, 2024 7:10 AM EST | Source: Delivra Health Brands Inc.Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company in the health and wellness sector, is pleased to announce its financial and operating results for the t ...